On 6 and 7 December, the Centre for the Law of EU External Relations (CLEER), which is hosted by the T.M.C. Asser Institute, celebrated its 10th anniversary with a conference on

Cancer is one of the main causes of death in the Netherlands. Leiden researchers are working to improve the treatment of different types of cancer in order to increase the patient’s quality of life. A better understanding of how cancer develops will make it possible to deliver personalised and precise…

On 15 November 2019, Dr. Joris Larik, Assistant Professor at LUC and Convener of the International Justice major, convened a policy roundtable on “Brexit’s Next Chapter: The Revised Deal and Global Britain” .

On 1 March Armin Cuvyers was interviewed on BNR national radio on Brexit, the Draft Withdrawal Agreement of the Commission and the key Brexit speech by Theresa May planned for 2 March.

Ewa Snaar-Jagalska, Shuning He and colleagues from IBL, LION and LACDR reported on a new zebrafish study to understand micrometastasis of human cancer cells. They discovered a novel role for neutrophils in assisting metastasis formation, which provides critical insights for anti-cancer therapies.

On 5 April 2017, Prof. Christa Tobler gave a guest lecture at the Centre for European Studies of the O.P Jindal Global University in Delhi on the topic of „“Brexit“ - what is it about and what could it mean for India?“

As of April 1, 2018, Erik Danen has been appointed as Professor of Cancer drug target discovery at the Leiden Academic Centre for Drug Research (LACDR). His discipline is cell biology of cancer, in which he focuses on the mechanisms underlying metastasis and therapy resistance.

On 11 December Armin Cuyvers, Associate Professor European Law at the Europa Institute of Leiden Law School, was a studio guest on the news programme EenVandaag to talk about the possible scenarios for Brexit.

Leiden University Medical Center (LUMC) has spent the past five years coordinating an international study of genetic mutations and breast cancer risks. The results will make it easier to determine which genes increase the risk of breast cancer and to what extent. The researchers published their results…

Joris Larik, Assistant Professor of Comparative, EU and International Law at LUC The Hague and Convener of the International Justice major, presented his research at the Midyear Meeting of the American Society of International Law, which was hosted by Brooklyn Law School in New York City.

Ariane Briegel wants to use bacteria to detect cancer at an early stage. Together with postdoc Alise Muok, she is developing a method to quickly and cheaply test the urine of patients for the presence of suspicious molecules. They receive a grant of approximately 150,000 euros from the Dutch Cancer…

The contribution ‘Article 50 TEU and Brexit: the legal contours of a political drama’ is the most read article of the Dutch Journal for EU Law (NtER).

In the BNR lobby panel, a topic is highlighted every week that lies at the intersection of entrepreneurship and politics. Arco Timmermans, Professor by Special Appointment of Public Affairs, talks about the effect of Brexit on lobbying in the EU.

Sebastian Pomplun manages to reach proteins with drugs even where this was thought impossible. That is why he and his research group have been allowed to join Oncode Institute. With nine others, he had been selected from 72 applicants to contribute to Oncode Institute's mission: to accelerate breakthroughs…

To inhibit proteins that contribute to the growth of aggressive cancer cells, that’s the plan of Professor Bob van de Water and his team. They will receive over 700,000 euros from the KWF Dutch Cancer Society for their research. Researcher Maaike Vreeswijk and pathologist Danielle Cohen are affiliated…

Switzerland and the EU are conducting negotiations on a renewed institutional framework for a number of already existing and future market access agreements.

With a Vici grant of 1.5 million euros, Professor of Mathematical biology Roeland Merks will look for ways to fix messy and leaky blood vessels in tumours. His research combines mathematical simulations and lab experiments in a unique way.

The British people have voted in favour of Brexit: the United Kingdom will leave the European Union. How will this vote be transformed into a legal and political reality?

The United Kingdom’s relationship with the European Union was supposed to be definitively settled several times during the past decade – yet it was not. The 2016 referendum brought about a surge in interest in legal questions, especially of EU law and international economic law. This presented scholars…

On Saturday 25 June 2016, the Europa Institute hosted the 55th Leiden-London Meeting, with the overall title:

Modified viruses can both kill cancer cells and activate the immune system. This is what an LUMC team discovered while researching a new prostate cancer therapy.

A therapeutic vaccine against HPV-16 (type 16 human papillomavirus) improves the survival rate in cervical cancer patients. A new study by ISA Pharmaceuticals B.V. (a Leiden-based biotechnology company) and the Leiden University Medical Center (LUMC) shows that this vaccine produces a more robust response…

Chemist Gerjan de Bruin has designed a method of slowing down the degradation process of proteins in cells. This may contribute to new cancer medicines with fewer side-effects. PhD defence on 1 June.

On Tuesday 24 April 2018, Nick Clegg, who served as Deputy Prime Minister of the United Kingdom, gave a guestlecture to first year students public administration about the profound dilemmas on Brexit. The lecture was part of a political science course within the Bachelor Public Administration of Leiden…

In breast cancer, metastasis rather than the primary tumour is the cause of death. A lack of oxygen in the tumour cells promotes this metastasis, accompanied by a reprogramming of the cell's metabolism. PhD candidate Qiuyu Liu investigated these alterations to get more knowledge about the actionable…

When internist Christian Blank made his very first discovery, his field of immunotherapy was the underdog of cancer research. Now, over 20 years later, Blank has been appointed Professor By Special Appointment of Internal Medicine for his clinical research into immunotherapy and will give his inaugural…

The shocking murder of MP Jo Cox has brought it home to the British public that the referendum debate is in disarray. How has the campaign been handled and what would be the consequences of a Brexit? Jan Rood, Professor by special appointment of European Integration, and political scientist Hans Vollaard…

We have followed the UK referendum of Thursday, 23 June 2016, with great interest and indeed concern.

Cell biologist Erik Danen has been awarderd a grant of half a million euros to study how tumor cells spread throughout the body en develop drug resistance. This was announced mid-August by the Dutch Cancer Society Fund (KWF).

Researchers of the Leiden University Medical Centre (LUMC) and the Leiden Institute of Chemistry have made an important discovery about the commonly used anti-cancer drug doxorubicin. They have found a way to reduce its side effects without sacrificing the effectiveness of the medication. This is encouraging…

Biological chemist Nathaniel Martin and his team received an NWO grant to examine how blocking a specific enzyme in our body, NNMT, could be helpful in the treatment of some cancers. Trials with mice have been promising, and together with the Netherlands Cancer Institute, Martin wants to take the next…

A cancer pill, preferably without severe side effects, is something we’d all welcome. Is it a matter of time before such a pill is a reality? We put this question to three Leiden researchers and asked how they themselves are contributing to new cancer treatments.

Researchers at Leiden University have mapped genes that cause breast cancer cells to migrate. The Leiden toxicologists Professor Bob van de Water, Dr Wies van Roosmalen, Dr Sylvia E. Le Dévédec and colleagues studied 1500 individual genes. They found eight, including the SRPK1 gene, that regulate the…

Chemotherapy that does nothing until you irradiate it with light. Sylvestre Bonnet receives a Vici grant of 1.5 million euros for the development of this treatment. The Leiden chemist wants to build a new molecule to fight tumours that are at the time still difficult to treat.

On 12 March 2021, Armin Cuyvers spoke on the issue of Euroscepticism and EU democracy post-Brexit in the multidisciplinary Winter School on Sustainable Global Futures: Knowledge, Democracy and Global Communications.

Will British universities become isolated after Brexit? The University of Oxford has set up a new programme for excellent young researchers to try to prevent that happening. Two Leiden PhD candidates are taking part. 'We have lost a lot of the citizens of Europe.'

In the days following Christmas, Christa Tobler gave a series of interviews to Swiss newspapers and Swiss radio about the new Trade and Cooperation Agreement between the EU and the UK and about what it might mean for Switzerland-EU relations and the draft EU-Swiss institutional framework agreement.

Leiden researchers have developed a groundbreaking model to advance cancer immunotherapy. Using a 3D printer, they create mini-tumors within an environment that closely mimics human tissue. They have also developed a method to monitor real-time interactions of these mini-tumours with immune cells during…

On 11 November Professor of Gastroenterology and Hepatology, Monique van Leerdam will deliver her inaugural lecture entitled, ‘Aiming for Prevention’. Van Leerdam, who specialises in hereditary tumours, was appointed professor in July 2020. In her inaugural lecture she will discuss the importance of…

Patients with incurable cancer want their oncologist to be clear but to show empathy too. They find hard and vague communication harmful. These are the results of a study by psychologists from Leiden that has been published in the American journal Cancer.

The advanced insights obtained for the CNS PBPK model development are currently used to develop advanced mathematical models for drug distribution prediction in other body tissues protected by barriers, such as the gut. The gut PBPK model will be linked to drug effects for treatment of colon cancer.

Liposomes hold great promise for peptide-based personalized cancer vaccination, especially when administered intradermally. However, current liposome preparation methods are very time consuming (resulting in long development times per formulation), whereas personalized cancer vaccination requires very…

This project is funded by the Dutch Cancer Society. The project will be part of an ongoing research line aimed at identifying mechanisms of cancer therapy resistance and metastasis. In this project, it will be investigated how the Grainyhead family of transcription factors controls therapy response…

PhD defence

In 2013, Sylvestre Bonnet received an ERC Starting Grant to kill cancer with molecules that can be activated by light. Two postdocs and three PhD students later, the end approaches of his so far successful project.

Death in all types of melanomas is generally caused by metastasis. Uveal melanoma (UM) is the most common intraocular melanoma, there are currently no (patient-derived) animal models that faithfully recapitulate metastatic dissemination of UM.

Researchers from the Leiden University Medical Center (LUMC) have developed an AI model that accurately predicts the risk of endometrial cancer recurrence.

When the immune system attacks cancer, the tumour modifies itself to escape the immune reaction. Researchers at LUMC published on this subject in Nature on 28 June.